tirzepatide weight loss clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide after intensive lifestyle intervention
Description
New Drug Forms Some online compounding pharmacies have begun selling oral forms of semaglutide and tirzepatide, which are typically administered with an injection
Karagiannis T, Malandris K, Avgerinos I, Stamati A, Kakotrichi P, Liakos A, et al
Nelson, L
Symptomatic relief: Over-the-counter antihistamines (such as cetirizine or loratadine) may help relieve itching and reduce hives
Regular check-ins with your healthcare provider are key to having a successful experience
Its unique feature is the combined effect on both receptor types, which may lead to more significant effects on glucose control and weight management
